The expression of ALDH1 protein in CSCs is a negative prognostic indicator and predictor of poor clinical outcomes in cancer patients, and high ALDH activity has been attributed to chemoresistant CSCs in different tumor types[150-152]. Here, ALDH1A1 is linked to cancer.